The CardioTag device fuses multiple sensing modalities to capture unique insights about the relationship between cardiac mechanics, electrical impulses, and blood flow – valuable inputs that can be used by AI algorithms to assess cardiac pressures and volume status CHICAGO–July 29, 2025–Cardiosense, a medical AI company transforming cardiovascular disease management, […]
Other News
Novasight™ Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case
TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intravascular imaging, is pleased to announce the publication of a compelling case report in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlighting the clinical impact of the Company’s Novasight™ Hybrid IVUS-OCT System in guiding accurate diagnosis and optimal stent placement in a complex coronary artery case. The case was performed, and the images were collected using the first-generation Novasight Hybrid IVUS-OCT system.
Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases
PORTAGE, Mich., July 29, 2025 /PRNewswire/ — Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access…
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee Blockages LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced enrollment of the first […]
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its groundbreaking MAGiC Sweep™ catheter. MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology (EP) mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers…
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its financial results for the fiscal year ended April 30, 2025, and provided a business update highlighting significant strategic progress.
GNT Pharma Receives Regulatory Approval to Initiate Multinational Phase 3 Clinical Trials for its Breakthrough Stroke Therapy ‘ Nelonemdaz™ ‘
NEW YORK, July 24, 2025 /PRNewswire/ — GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 Clinical Trials of its lead drug Nelonemdaz, has been approved by MFDS – South Korea’s…
Heart Failure Society of America Celebrates 30 Years with Lineup of Visionary Leaders at Annual Scientific Meeting 2025
Saturday Plenary to Spotlight Innovations in Heart Failure Research, AI, and Future Care Models WASHINGTON, July 24, 2025 /PRNewswire/ — The Heart Failure Society of America (HFSA) is marking 30 years of leadership in heart failure care with a dynamic celebration at the HFSA Annual…
Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring
July 24, 2025



